The selection of the GF analyzed in this study was performed due to previous studies, mainly in preclinical models of cerebral ischemia, since there is a gap in studies in clinical practice which may be one of the reasons why clinical trials with GF such as G-CSF have failed [13, 14]. This evidence concerns the gene CSF3 and brain ischemia.